Home/Filings/4/0001787306-24-000155
4//SEC Filing

Curran Terrie 4

Accession 0001787306-24-000155

CIK 0001787306other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 6:45 PM ET

Size

5.2 KB

Accession

0001787306-24-000155

Insider Transaction Report

Form 4
Period: 2024-11-11
Transactions
  • Sale

    Common Stock

    2024-11-11$10.85/sh8,687$94,23810,139 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.7542 to $10.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001690298

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 6:45 PM ET
Size
5.2 KB